Accentuated transdermal application of glucosamine sulphate attenuates experimental osteoarthritis induced by monosodium iodoacetate
- 14 June 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 4 (25) , 4470-4481
Abstract
Osteoarthritis is a chronic degenerative joint disease causing pain and disability. Glucosamine sulphate is a well known oral supplement for its treatment. The present pioneering study provides an overview of the accentuated transdermal delivery of glucosamine sulphate through the optimized gel formulation with guar gum and sodium carboxymethyl cellulose (Na-CMC). Response surface methodology based on the three-level three-factor central composite design provided the optimum concentration of guar gum, Na-CMC and glycerol for a maximum flux. The transdermal characterization, ex vivo permeation study and in vivo study were performed with optimized gel formulation. The factorial design predicted the optimum values of guar gum, Na-CMC and glycerol which were 418.53 mg, 444.97 mg and 2322.4 mg respectively for 25 g of the gel. This optimized gel demonstrated the maximum flux, i.e., 1047.46 μg cm−2 h−1. The optimized gel showed satisfactory results with respect to drug uniformity, pH, stability, rheological properties, zeta potential, drug–excipient compatibility and skin irritation. The release of the drug from the optimized transdermal gel followed the controlled first order Fickian (non-steady) release pattern. The in vivo study was carried out in a rat model of osteoarthritis induced by monosodium iodoacetate damaging the tibial plateau. In this study the optimized formulation effectively reduced the symptoms like reduction in swelling of the knee joint, gross changes in digitized radio images and morphological and histopathological alterations. Additionally the changes in the release pattern of the proinflammatory cytokine tumor necrosis factor-α illustrated the efficacy of the transdermal gel for the treatment of experimental osteoarthritis. Thus the optimized gel was found to be a unique potential vehicle for transdermal application of glucosamine sulphate which effectively attenuates the experimental osteoarthritis.Keywords
This publication has 42 references indexed in Scilit:
- Pain Treatment in Arthritis-Related Pain: Beyond NSAIDsThe Open Rheumatology Journal, 2012
- Monosodium iodoacetate induces apoptosis via the mitochondrial pathway involving ROS production and caspase activation in rat chondrocytes in vitroJournal of Orthopaedic Research, 2012
- Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugsBiomaterials, 2012
- A 3D cartilage – Inflammatory cell culture system for the modeling of human osteoarthritisBiomaterials, 2011
- Recent aspects of the anti-inflammatory actions of glucosamineCarbohydrate Polymers, 2011
- Glucosamine sulfate reduces experimental osteoarthritis and nociception in rats: association with changes of mitogen-activated protein kinase in chondrocytesOsteoarthritis and Cartilage, 2010
- Collagenase and Sodium Iodoacetate-Induced Experimental Osteoarthritis Model in Sprague Dawley RatsAsian Journal of Scientific Research, 2009
- Development of a simple analytical methodology for determination of glucosamine release from modified release matrix tabletsJournal of Pharmaceutical and Biomedical Analysis, 2005
- Mono-Iodoacetate-Induced Histologic Changes in Subchondral Bone and Articular Cartilage of Rat Femorotibial Joints: An Animal Model of OsteoarthritisToxicologic Pathology, 2003
- Immunosuppressive Effects of GlucosamineJournal of Biological Chemistry, 2002